Cerebral is offering an alternative to a mental health system that many see as broken.
SAN FRANCISCO (PRWEB) January 21, 2020
Cerebral has launched publicly in California, Florida, Georgia, Maryland, Ohio, Pennsylvania, and Texas.
The startup is reimagining the process by which people are treated for anxiety and depression. Clients sign up for a comprehensive subscription, which allows them to schedule an initial visit to be held within days of signing up. If they are prescribed medication during their visit, they are then assigned to a care manager who works closely with them and can respond to any questions or concerns within a day.
All of this happens online, and medication is delivered directly to the person’s home for no extra charge. Dosage and medication adjustments are common in psychiatric care, so clients have regular check-ins to figure out when changes to a treatment regimen are needed.
The founders include Dr. Ho Anh, the former Medical Director at Hims and former Medical Group President at Lemonaid Health, as well as Kyle Robertson, who has deep family and personal connections to mental health.
Cerebral is currently offering a discount for the first month to make care for Seasonal Affective Disorder more accessible, with the price at just $5 for the first month of treatment for those who start before February 1st.
The startup is a new alternative to a broken traditional mental health care system. 18.1% of American adults are suffering from an anxiety disorder at any given time. What’s scary is that only 1 in 5 of them receive treatment consistent with current practice guidelines, and 35% receive no treatment at all. 3 month wait times are average to see a psychiatrist. And they’re often waiting for a consultation that they’ll have to pay $500 for.
For $92 per month, comprehensive care at Cerebral includes:
- Video visits with a prescribing provider
- Medication & medication delivery
- Assigned care manager
For the past 3 months, Cerebral ran a private beta in California & Ohio. Early indicators of clinical efficacy are promising, and the team is excited to continue tracking this over the course of the months and years to come.
This promising new line of treatment is getting interest around the country. Bloomberg ran an exclusive look on what this launch means to the industry.
Clients looking for treatment as well as mental health professionals looking for options for their own clients should learn more about Cerebral on the company's website.